| BCBS Texas Medical Policies | Obinutuzumab | 2026-07-15 |
| BCBS New Mexico Medical Policies | Biomarker Testing in Risk Assessment and Management of | 2026-07-15 |
| BCBS New Mexico Medical Policies | Obinutuzumab | 2026-07-15 |
| BCBS Montana Medical Policies | Biomarker Testing in Risk Assessment and Management of | 2026-07-15 |
| BCBS Montana Medical Policies | Obinutuzumab | 2026-07-15 |
| Medicare Wellpoint NGS | Billing and Coding: Botulinum Toxin Injections (59707) | 2026-07-15 |
| Medicare Wellpoint NGS | Billing and Coding: Pharmacogenomic Testing (59915) | 2026-07-15 |
| Aetna | Botulinum Toxin | 2026-07-14 |
| Aetna | Glaucoma Surgery | 2026-07-14 |
| BCBS Kansas | Varicose Veins | 2026-07-14 |